PROMACTA (Eltrombopag) is a prescription medication used to treat certain blood disorders by increasing platelet production in the body. This innovative treatment is primarily indicated for patients with chronic immune thrombocytopenic purpura (ITP), chronic hepatitis C, and severe aplastic anemia. By stimulating the thrombopoietin receptor, Eltrombopag promotes the formation of platelets, which are crucial for proper blood clotting and overall health.